P140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation

Oncogene

Volumn 29, Issue 25, 2010, Pages 3677-3690

  Damiano, L ^a   Di Stefano, P ^a   Camacho Leal, M P ^a   Barba, M ^b   Mainiero, F ^b   Cabodi, S ^a   Tordella, L ^a   Sapino, A ^c   Castellano, I ^c   Canel, M ^d   Frame, M ^d   Turco, E ^a   Defilippi, P ^a  

^a Molecular Biotechnology Center   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; P140CAP; RAS PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MEMBRANE; CELL MOTILITY; CELL PROLIFERATION; CELL SCATTER; CELLULAR PARAMETERS; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENETIC REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TUMOR CELL;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; NEOPLASMS; PROTEIN STABILITY; RAS PROTEINS; RECEPTOR CROSS-TALK; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 77954088797     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.128     Document Type: Article

References (32)

1. Alema S, Salvatore AM. (2007). p120 catenin and phosphorylation: mechanisms and traits of an unresolved issue. Biochim Biophys Acta 1773: 47-58.
2. Aronheim A, Engelberg D, Li N, al-Alawi N, Schlessinger J, Karin M. (1994). Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78: 949-961.
3. Arteaga CL. (2002). Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7(Suppl 4): 31-39.
4. Berx G, Raspe E, Christofori G, Thiery JP, Sleeman JP. (2007). Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis 24: 587-597.
5. Berx G, Van Roy F. (2001). The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 3: 289-293.
6. Cavallaro U, Christofori G. (2004). Multitasking in tumor progression: signaling functions of cell adhesion molecules. Ann N Y Acad Sci 1014: 58-66.
7. Chin LS, Nugent RD, Raynor MC, Vavalle JP, Li L. (2000). SNIP, a novel SNAP-25-interacting protein implicated in regulated exocytosis. J Biol Chem 275: 1191-1200.
8. Coleman ML, Marshall CJ, Olson MF. (2004). RAS and RHO GTPases in G1-phase cell-cycle regulation. Nat Rev Mol Cell Biol 5: 355-366.
9. Di Stefano P, Cabodi S, Boeri Erba E, Margaria V, Bergatto E, Giuffrida MG et al (2004). P130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated protein involved in cell spreading. Mol Biol Cell 15: 787-800.
10. Di Stefano P, Damiano L, Cabodi S, Aramu S, Tordella L, Praduroux A et al (2007). p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity. Embo J 26: 2843-2855.
11. Giancotti FG, Tarone G. (2003). Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 19: 173-206.
12. Glynn RW, Miller N, Kerin MJ. (2010). 17q12-21\The pursuit of targeted therapy in breast cancer. Cancer Treat Rev 36: 224-229.
13. Guo W, Giancotti FG. (2004). Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826.
14. Gutkind JS. (2000). Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci STKE 2000: re1.
15. Kennedy S, Clynes M, Doolan P, Mehta JP, Rani S, Crown J et al (2008). SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue. Br J Cancer 98: 1641-1645.
16. Kim H, Muller WJ. (1999). The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. Exp Cell Res 253: 78-87.
17. Lacroix M, Leclercq G. (2004). Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83: 249-289.
18. Miranda KC, Khromykh T, Christy P, Le TL, Gottardi CJ, Yap AS et al. (2001). A dileucine motif targets E-cadherin to the basolateral cell surface in Madin-Darby canine kidney and LLC-PK1 epithelial cells. J Biol Chem 276: 22565-22572.
19. Nicholson RI, Gee JM, Harper ME. (2001). EGFR and cancer prognosis. Eur J Cancer 37(Suppl 4): S9-15.
20. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR et al (2006). Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366: 2-16.
21. Peinado H, Olmeda D, Cano A. (2007). Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428.
22. Perrais M, Chen X, Perez-Moreno M, Gumbiner BM. (2007). E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol Biol Cell 18: 2013-2025.
23. Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR. (2004). E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. Embo J 23: 1739-1748.
24. Reynolds AB. (2007). p120-catenin: Past and present. Biochim Biophys Acta 1773: 2-7.
25. Reynolds AB, Carnahan RH. (2004). Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer. Semin Cell Dev Biol 15: 657-663.
26. Sasaki CY, Lin H, Morin PJ, Longo DL. (2000). Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin. Cancer Res 60: 7057-7065.
27. Schlessinger J. (2000). Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
28. Schubbert S, Shannon K, Bollag G. (2007). Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7: 295-308.
29. Sorkin A, McClure M, Huang F, Carter R. (2000). Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr Biol 10: 1395-1398.
30. Takahashi K, Suzuki K. (1996). Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion. Exp Cell Res 226: 214-222.
31. Vestweber D, Kemler R. (1985). Identification of a putative cell adhesion domain of uvomorulin. Embo J 4: 3393-3398.
32. Yamasaki S, Nishida K, Yoshida Y, Itoh M, Hibi M, Hirano T. (2003). Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2. Oncogene 22: 1546-1556.